Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders (P7-6.020)
This study aims to evaluate clinical experiences with vesicular monoamine transporter 2 (VMAT2) inhibitors in pediatric hyperkinetic movement disorders.
Authors
- Mariam Hull (ORCID: https://orcid.org/0000-0002-7340-1660)
- Sujal Manohar (ORCID: https://orcid.org/0000-0001-7128-7043)
- Ruud Berger (ORCID: https://orcid.org/0009-0009-1790-3672)
- Jennifer Jacobe
Institutions
- Baylor College of Medicine (US)
- Texas Children's Hospital (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208995
- Primary Topic
- Biochemical and Molecular Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00